General AML,   IDH1/2,  FLT3

ASH 2018 | Practice changing abstracts in acute myeloid leukemia 

Did you miss ASH 2018? The AML Global Portal attended the 60th ASH Annual Meeting & Exposition, December 1–4 2018, San Diego, CA, USA, and has developed a downloadable resource, which provides information on the practice changing abstracts across acute myeloid leukemia (AML).

Our selection of ASH abstracts include comments from the AML Global Portal Steering Committee members on transplantation in AML, venetoclax as new standard of care, IDH1/2 inhibitors, maintenance therapy, MRD status, and the findings of the phase III Quantum-R trial.

ASH 2018 | Practice changing abstracts in acute myeloid leukemia

If you would like to view the ASH 2018 highlights, practice changing abstracts and expert opinions please find the AML Global Portal resource below

Download Here
Was this article informative? Thank you for your feedback!
83% of people found this article informative